-
1
-
-
85015555812
-
Report on the consultative meeting on Leishmania/HIV co-infection. report no. WHO/LEISH/95.35, pp
-
World Health Organization. (1995) Report on the consultative meeting on Leishmania/HIV co-infection. report no. WHO/LEISH/95.35, pp. 1–14. Geneva: World Health Organization.
-
(1995)
-
-
-
2
-
-
0033093302
-
Epidemiology of visceral leishmaniasis in india
-
Bora D, (1999) Epidemiology of visceral leishmaniasis in india. Natl Med J India 12: 62–68.
-
(1999)
Natl Med J India
, vol.12
, pp. 62-68
-
-
Bora, D.1
-
3
-
-
84869811408
-
Estimate of HIV prevalence and number of people living with HIV in india 2008–2009
-
Pandey A, Sahu D, Bakkali T, Reddy D, Venkatesh S, et al. (2012) Estimate of HIV prevalence and number of people living with HIV in india 2008–2009. BMJ Open 2: e000926 doi:10.1136/bmjopen-2012-000926
-
(2012)
BMJ Open
, vol.2
, pp. e000926
-
-
Pandey, A.1
Sahu, D.2
Bakkali, T.3
Reddy, D.4
Venkatesh, S.5
-
4
-
-
85015555508
-
-
Government of India, Ministry of Health and Family Welfare. (2010) United Nations general assembly special session on HIV/AIDS country report: India.
-
(2010)
-
-
-
5
-
-
84873495696
-
T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: Is this paradigm still relevant?
-
Alexander J, Brombacher F, (2012) T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: Is this paradigm still relevant? Front Immunol 3: 80 doi:10.3389/fimmu.2012.00080
-
(2012)
Front Immunol
, vol.3
, pp. 80
-
-
Alexander, J.1
Brombacher, F.2
-
6
-
-
84861214279
-
Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection
-
Mock DJ, Hollenbaugh JA, Daddacha W, Overstreet MG, Lazarski CA, et al. (2012) Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection. PLoS Pathog 8: e1002635 doi:10.1371/journal.ppat.1002635
-
(2012)
PLoS Pathog
, vol.8
, pp. e1002635
-
-
Mock, D.J.1
Hollenbaugh, J.A.2
Daddacha, W.3
Overstreet, M.G.4
Lazarski, C.A.5
-
7
-
-
84871803448
-
Clinical aspects of visceral leishmaniasis in HIV infection
-
Jarvis JN, Lockwood DN, (2013) Clinical aspects of visceral leishmaniasis in HIV infection. Curr Opin Infect Dis 26: 1–9 doi:10.1097/QCO.0b013e32835c2198
-
(2013)
Curr Opin Infect Dis
, vol.26
, pp. 1-9
-
-
Jarvis, J.N.1
Lockwood, D.N.2
-
8
-
-
42349108596
-
The relationship between leishmaniasis and AIDS: The second 10 years
-
Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The relationship between leishmaniasis and AIDS: The second 10 years. Clin Microbiol Rev 21: 334–59 table of contents. doi:10.1128/CMR.00061-07
-
(2008)
Clin Microbiol Rev
, vol.21
, pp. 334-359
-
-
Alvar, J.1
Aparicio, P.2
Aseffa, A.3
Den Boer, M.4
Canavate, C.5
-
9
-
-
0037231571
-
Visceral leishmaniasis and HIV coinfection in Bihar, India
-
Sinha PK, Rabidas VN, Pandey K, Verma N, Gupta AK, et al. (2003) Visceral leishmaniasis and HIV coinfection in Bihar, India. J Acquir Immune Defic Syndr 32: 115–116.
-
(2003)
J Acquir Immune Defic Syndr
, vol.32
, pp. 115-116
-
-
Sinha, P.K.1
Rabidas, V.N.2
Pandey, K.3
Verma, N.4
Gupta, A.K.5
-
10
-
-
0037446441
-
Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: Is this combination increasing?
-
Thakur CP, Narayan S, Ranjan A, (2003) Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: Is this combination increasing? J Acquir Immune Defic Syndr 32: 572–573.
-
(2003)
J Acquir Immune Defic Syndr
, vol.32
, pp. 572-573
-
-
Thakur, C.P.1
Narayan, S.2
Ranjan, A.3
-
11
-
-
33646894714
-
Leishmania-HIV co-infection: An emerging problem in India
-
Redhu NS, Dey A, Balooni V, Singh S, (2006) Leishmania-HIV co-infection: An emerging problem in India. AIDS 20: 1213–1215 doi:10.1097/01.aids.0000226971.42622.4e
-
(2006)
AIDS
, vol.20
, pp. 1213-1215
-
-
Redhu, N.S.1
Dey, A.2
Balooni, V.3
Singh, S.4
-
12
-
-
33745662611
-
Visceral leishmaniasis/human immunodeficiency virus co-infection in India: The focus of two epidemics
-
Mathur P, Samantaray JC, Vajpayee M, Samanta P, (2006) Visceral leishmaniasis/human immunodeficiency virus co-infection in India: The focus of two epidemics. J Med Microbiol 55: 919–922 doi:10.1099/jmm.0.46574-0
-
(2006)
J Med Microbiol
, vol.55
, pp. 919-922
-
-
Mathur, P.1
Samantaray, J.C.2
Vajpayee, M.3
Samanta, P.4
-
13
-
-
0033653794
-
Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in india
-
Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S, (2000) Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in india. Trans R Soc Trop Med Hyg 94: 696–697.
-
(2000)
Trans R Soc Trop Med Hyg
, vol.94
, pp. 696-697
-
-
Thakur, C.P.1
Sinha, P.K.2
Singh, R.K.3
Hassan, S.M.4
Narain, S.5
-
14
-
-
84905017602
-
HIV and visceral leishmaniasis co-infection in Bihar, India: An under-recognised and under-diagnosed threat against elimination
-
Burza S, Mahajan R, Sanz MG, Sunyoto T, Kumar R, et al. (2014) HIV and visceral leishmaniasis co-infection in Bihar, India: An under-recognised and under-diagnosed threat against elimination. Clin Infect Dis E-pub ahead of print. doi:10.1093/cid/ciu333
-
(2014)
Clin Infect Dis
-
-
Burza, S.1
Mahajan, R.2
Sanz, M.G.3
Sunyoto, T.4
Kumar, R.5
-
15
-
-
84878484762
-
Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: A systematic review with indirect comparison
-
Cota GF, de Sousa MR, Fereguetti TO, Rabello A, (2013) Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: A systematic review with indirect comparison. PLoS Negl Trop Dis 7: e2195 doi:10.1371/journal.pntd.0002195
-
(2013)
PLoS Negl Trop Dis
, vol.7
, pp. e2195
-
-
Cota, G.F.1
de Sousa, M.R.2
Fereguetti, T.O.3
Rabello, A.4
-
16
-
-
84870410906
-
Liposomal amphotericin B as a treatment for human leishmaniasis
-
Balasegaram M, Ritmeijer K, Lima MA, Burza S, Ortiz Genovese G, et al. (2012) Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opin Emerg Drugs 17: 493–510 doi:10.1517/14728214.2012.748036
-
(2012)
Expert Opin Emerg Drugs
, vol.17
, pp. 493-510
-
-
Balasegaram, M.1
Ritmeijer, K.2
Lima, M.A.3
Burza, S.4
Ortiz Genovese, G.5
-
17
-
-
80052431603
-
Report of a meeting of the WHO expert committee on the control of leishmaniasis
-
WHO control of the leishmaniasis (2010) Report of a meeting of the WHO expert committee on the control of leishmaniasis, 22–26 March 2010. Geneva: WHO.
-
(2010)
-
-
-
18
-
-
84893752352
-
Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (ambisome) for visceral leishmaniasis in Bihar, India
-
Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, et al. (2014) Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (ambisome) for visceral leishmaniasis in Bihar, India. PLoS Negl Trop Dis 8: e2603 doi:10.1371/journal.pntd.0002603
-
(2014)
PLoS Negl Trop Dis
, vol.8
, pp. e2603
-
-
Burza, S.1
Sinha, P.K.2
Mahajan, R.3
Lima, M.A.4
Mitra, G.5
-
19
-
-
0036733664
-
Laboratory diagnosis of visceral leishmaniasis
-
Sundar S, Rai M, (2002) Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 9: 951–958.
-
(2002)
Clin Diagn Lab Immunol
, vol.9
, pp. 951-958
-
-
Sundar, S.1
Rai, M.2
-
20
-
-
85015548702
-
-
World Health Organization (2011) Field safety notice no. 1, 2011. Available: Http://www.who.int/diagnostics_laboratory/procurement/111201_productalert_for_product0027_mx012.pdf. Accessed 25 January 2014.
-
-
-
-
21
-
-
85015545883
-
-
World Health Organization (2010) Indicators for monitoring and evaluation of the kala-azar elimination programme. Available: http://www.who.int/tdr/publications/documents/kala_azar_indicators.pdf. Accessed 1 June 2014.
-
-
-
-
22
-
-
77955591768
-
Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India
-
Sinha PK, Roddy P, Palma PP, Kociejowski A, Lima MA, et al. (2010) Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India. Am J Trop Med Hyg 83: 357–364 doi:10.4269/ajtmh.2010.10-0156
-
(2010)
Am J Trop Med Hyg
, vol.83
, pp. 357-364
-
-
Sinha, P.K.1
Roddy, P.2
Palma, P.P.3
Kociejowski, A.4
Lima, M.A.5
-
23
-
-
80052502527
-
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India
-
Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, et al. (2011) Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India. Clin Infect Dis 53: e91 doi:10.1093/cid/cir521
-
(2011)
Clin Infect Dis
, vol.53
, pp. e91
-
-
Sinha, P.K.1
van Griensven, J.2
Pandey, K.3
Kumar, N.4
Verma, N.5
-
24
-
-
20344370565
-
Multiple imputation of missing values
-
Royston P, (2004) Multiple imputation of missing values. Stata Journal 4: 227–241.
-
(2004)
Stata Journal
, vol.4
, pp. 227-241
-
-
Royston, P.1
-
25
-
-
67651112075
-
Competing risk regression models for epidemiologic data
-
Lau B, Cole SR, Gange SJ, (2009) Competing risk regression models for epidemiologic data. Am J Epidemiol 170: 244–256 doi:10.1093/aje/kwp107
-
(2009)
Am J Epidemiol
, vol.170
, pp. 244-256
-
-
Lau, B.1
Cole, S.R.2
Gange, S.J.3
-
26
-
-
0030915453
-
Non-parametric inference for cumulative incidence functions in competing risks studies
-
Lin DY, (1997) Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 16: 901–910.
-
(1997)
Stat Med
, vol.16
, pp. 901-910
-
-
Lin, D.Y.1
-
27
-
-
79959822382
-
Predictors of visceral leishmaniasis relapse in HIV-infected patients: A systematic review
-
Cota GF, de Sousa MR, Rabello A, (2011) Predictors of visceral leishmaniasis relapse in HIV-infected patients: A systematic review. PLoS Negl Trop Dis 5: e1153 doi:10.1371/journal.pntd.0001153
-
(2011)
PLoS Negl Trop Dis
, vol.5
, pp. e1153
-
-
Cota, G.F.1
de Sousa, M.R.2
Rabello, A.3
-
28
-
-
43949118839
-
Concordant HIV infection and visceral leishmaniasis in Ethiopia: The influence of antiretroviral treatment and other factors on outcome
-
ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN, (2008) Concordant HIV infection and visceral leishmaniasis in Ethiopia: The influence of antiretroviral treatment and other factors on outcome. Clin Infect Dis 46: 1702–1709 doi:10.1086/587899
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1702-1709
-
-
ter Horst, R.1
Collin, S.M.2
Ritmeijer, K.3
Bogale, A.4
Davidson, R.N.5
-
29
-
-
81855160861
-
Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an ethiopian population with high HIV prevalence
-
Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, et al. (2011) Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an ethiopian population with high HIV prevalence. Clin Infect Dis 53: e152–8 doi:10.1093/cid/cir674
-
(2011)
Clin Infect Dis
, vol.53
, pp. e152-e158
-
-
Ritmeijer, K.1
ter Horst, R.2
Chane, S.3
Aderie, E.M.4
Piening, T.5
-
30
-
-
84893791064
-
Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (ambisome) in Bihar, India
-
Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, et al. (2014) Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (ambisome) in Bihar, India. PLoS Negl Trop Dis 8: e2536 doi:10.1371/journal.pntd.0002536
-
(2014)
PLoS Negl Trop Dis
, vol.8
, pp. e2536
-
-
Burza, S.1
Sinha, P.K.2
Mahajan, R.3
Lima, M.A.4
Mitra, G.5
-
31
-
-
84886933515
-
One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India
-
Burza S, Nabi E, Mahajan R, Mitra G, Lima MA, (2013) One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India. Clin Infect Dis 57: 1363–1364 doi:10.1093/cid/cit508
-
(2013)
Clin Infect Dis
, vol.57
, pp. 1363-1364
-
-
Burza, S.1
Nabi, E.2
Mahajan, R.3
Mitra, G.4
Lima, M.A.5
-
32
-
-
84877283879
-
Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance
-
Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, et al. (2013) Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 56: 1530–1538 doi:10.1093/cid/cit102
-
(2013)
Clin Infect Dis
, vol.56
, pp. 1530-1538
-
-
Rijal, S.1
Ostyn, B.2
Uranw, S.3
Rai, K.4
Bhattarai, N.R.5
-
33
-
-
85015544129
-
Antiretroviral therapy guidelines for HIV-infected adults and adolescents, including post-exposure prophylaxis
-
National AIDS Control Organization (2007) Antiretroviral therapy guidelines for HIV-infected adults and adolescents, including post-exposure prophylaxis, May 2007, 125 pp.
-
(2007)
May
, vol.2007
, pp. 125
-
-
-
34
-
-
84879146007
-
Adherence to antiretroviral therapy and its effect on survival of HIV-infected individuals in Jharkhand, India
-
Rai S, Mahapatra B, Sircar S, Raj PY, Venkatesh S, et al. (2013) Adherence to antiretroviral therapy and its effect on survival of HIV-infected individuals in Jharkhand, India. PLoS One 8: e66860 doi:10.1371/journal.pone.0066860
-
(2013)
PLoS One
, vol.8
, pp. e66860
-
-
Rai, S.1
Mahapatra, B.2
Sircar, S.3
Raj, P.Y.4
Venkatesh, S.5
-
35
-
-
85015543336
-
-
National AIDS Control Organization And Central TB Division (2010) Ministry of health & family welfare government of India, New Delhi. TB/HIV module for ART centre staff. Available: http://www.tbcindia.nic.in/pdfs/TB-HIV%20Module%20for%20ART%20Centre%20Staff.pdf. Accessed: 1 May 2014.
-
-
-
-
36
-
-
85015546064
-
-
National AIDS Control organisation Ministry of Health and Family Welfare Government of India (2012) Operational guidelines for ART services 2012. Available: Http://www.naco.gov.in/upload/Publication/Treatment%20Care%20and%20support/Operational%20guidelines%20for%20ART%20services.pdf Accessed 26 January 2014.
-
-
-
-
37
-
-
77049105214
-
Combination therapy for visceral leishmaniasis
-
van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, et al. (2010) Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10: 184–194 doi:10.1016/S1473-3099(10)70011-6
-
(2010)
Lancet Infect Dis
, vol.10
, pp. 184-194
-
-
van Griensven, J.1
Balasegaram, M.2
Meheus, F.3
Alvar, J.4
Lynen, L.5
-
38
-
-
84862944418
-
Mechanism of amphotericin B resistance in clinical isolates of leishmania donovani
-
Purkait B, Kumar A, Nandi N, Sardar AH, Das S, et al. (2012) Mechanism of amphotericin B resistance in clinical isolates of leishmania donovani. Antimicrob Agents Chemother 56: 1031–1041 doi:10.1128/AAC.00030-11
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 1031-1041
-
-
Purkait, B.1
Kumar, A.2
Nandi, N.3
Sardar, A.H.4
Das, S.5
-
39
-
-
0031903651
-
Leishmania infantum: Lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis
-
Durand R, Paul M, Pratlong F, Rivollet D, Dubreuil-Lemaire ML, et al. (1998) Leishmania infantum: Lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrob Agents Chemother 42: 2141–2143.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 2141-2143
-
-
Durand, R.1
Paul, M.2
Pratlong, F.3
Rivollet, D.4
Dubreuil-Lemaire, M.L.5
-
40
-
-
58749113633
-
Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and leishmania infantum
-
Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, et al. (2009) Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and leishmania infantum. Clin Infect Dis 48: e16–22 doi:10.1086/595710
-
(2009)
Clin Infect Dis
, vol.48
, pp. e16-22
-
-
Lachaud, L.1
Bourgeois, N.2
Plourde, M.3
Leprohon, P.4
Bastien, P.5
-
41
-
-
84904369974
-
Multiple relapses of viceral leishmaniasis in a patient with HIV in India: A treatment challenge. International journal of infectious diseases
-
Patole S, Burza S, Varghese G, (2014) Multiple relapses of viceral leishmaniasis in a patient with HIV in India: A treatment challenge. International journal of infectious diseases. Int J Infect Dis E-pub ahead of print. doi:10.1016/j.ijid.2014.02.015
-
(2014)
Int J Infect Dis
-
-
Patole, S.1
Burza, S.2
Varghese, G.3
-
42
-
-
80055078978
-
Incidence of symptomatic and asymptomatic leishmania donovani infections in high-endemic foci in India and Nepal: A prospective study
-
Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, et al. (2011) Incidence of symptomatic and asymptomatic leishmania donovani infections in high-endemic foci in India and Nepal: A prospective study. PLoS Negl Trop Dis 5: e1284 doi:10.1371/journal.pntd.0001284
-
(2011)
PLoS Negl Trop Dis
, vol.5
, pp. e1284
-
-
Ostyn, B.1
Gidwani, K.2
Khanal, B.3
Picado, A.4
Chappuis, F.5
-
43
-
-
85015552851
-
-
National vector borne disease control programme (2008) Directorate general of health services, ministry of health and family welfare. project implementation plan: National vector borne disease control support project under world bank on malaria control & kala-azar elimination (2008–2013). Available: Http://nvbdcp.gov.in/Doc/PIP.pdf. Accessed 20 January 2014.
-
-
-
|